Biodesix, Inc.
BDSX
$0.3632
$0.01153.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.96M | 20.43M | 18.15M | 17.93M | 14.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.96M | 20.43M | 18.15M | 17.93M | 14.82M |
| Cost of Revenue | 3.70M | 4.34M | 4.18M | 3.88M | 3.18M |
| Gross Profit | 14.26M | 16.09M | 13.97M | 14.05M | 11.64M |
| SG&A Expenses | 20.45M | 20.22M | 20.02M | 19.66M | 20.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.02M | 26.98M | 26.74M | 26.10M | 25.77M |
| Operating Income | -9.06M | -6.55M | -8.59M | -8.17M | -10.95M |
| Income Before Tax | -11.10M | -8.25M | -10.26M | -10.81M | -13.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.10M | -8.25M | -10.26M | -10.81M | -13.61M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.10M | -8.25M | -10.26M | -10.81M | -13.61M |
| EBIT | -9.06M | -6.55M | -8.59M | -8.17M | -10.95M |
| EBITDA | -7.62M | -5.10M | -7.10M | -6.76M | -9.53M |
| EPS Basic | -0.08 | -0.06 | -0.07 | -0.09 | -0.14 |
| Normalized Basic EPS | -0.05 | -0.03 | -0.04 | -0.05 | -0.09 |
| EPS Diluted | -0.08 | -0.06 | -0.07 | -0.09 | -0.14 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.04 | -0.05 | -0.09 |
| Average Basic Shares Outstanding | 146.55M | 146.60M | 146.30M | 127.17M | 97.17M |
| Average Diluted Shares Outstanding | 146.55M | 146.60M | 146.30M | 127.17M | 97.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |